Ubiquinol

DB11340ApprovedInvestigationalSmall molecule

Ubiquinol (CoQH2) is a reduced form of coenzyme Q10 (CoQ10) that acts as an active antioxidant that prevents the initiation and propagation of lipid peroxidation in biological membranes and human... It plays an essential role in maintaining cellular defense against oxidative damage and also sustains the effects of vitamin E by regenerating the vitamin from the tocopheroxyl radical, but ubiquinol is not classified as a...

Formula / weight: C₅₉H₉₂O₄ · 865.3594 g/mol (avg)

Resolves to

Compound

UNIIM9NL0C577YCAS992-78-9ChEBI64183PubChem9962735

Clinical / RWD

RxNorm39085

Structure

InChIKeyQNTNKSLOFHEFPK-UPTCCGCDSA-NSMILES

COC1=C(OC)C(O)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(C)=C1O

Targets

Q9NY59SMPD3O60906SMPD2

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

2Marketed productsAcross 1 country and 1 labeller

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ubiquinol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account